Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
KDM6B overexpression + TET2 deletion
i
Other names:
KDM6B, Lysine Demethylase 6B, Jumonji Domain Containing 3 Histone Lysine Demethylase, Jumonji Domain-Containing Protein 3, Lysine (K)-Specific Demethylase 6B, JmjC Domain-Containing Protein 3, Lysine-Specific Demethylase 6B, JMJD3, Jumonji Domain Containing, KIAA0346, NEDCFSA, TET2, Tet Methylcytosine Dioxygenase 2, KIAA1546, Methylcytosine Dioxygenase TET2, Tet Oncogene Family Member 2, Probable Methylcytosine Dioxygenase TET2, MDS
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
54790
;
23135
Related biomarkers:
Expression
Mutation
CNA
Others
‹
TET2 mutation (18)
BRAF mutation + TET2 mutation (1)
NPM1 mutation + FLT3-ITD mutation + TET2 mutation + CUX1 mutation (1)
TET2 E227 (1)
TET2 L1231P (1)
TET2 mutation + NRAS mutation (1)
MECOM mutation + KDM6B mutation (1)
TET2 mutation + DNMT3A mutation (0)
TET2 mutation (18)
BRAF mutation + TET2 mutation (1)
NPM1 mutation + FLT3-ITD mutation + TET2 mutation + CUX1 mutation (1)
TET2 E227 (1)
TET2 L1231P (1)
TET2 mutation + NRAS mutation (1)
MECOM mutation + KDM6B mutation (1)
TET2 mutation + DNMT3A mutation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
KDM6B overexpression + TET2 deletion
Chronic Myelomonocytic Leukemia
KDM6B overexpression + TET2 deletion
Chronic Myelomonocytic Leukemia
GSKJ4
Sensitive: D – Preclinical
GSKJ4
Sensitive
:
D
GSKJ4
Sensitive: D – Preclinical
GSKJ4
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.